While previous work has suggested a connection between RAS signaling and CDCP1 in lung cancers (Uekita et al., 2014), our work now demonstrates MAPK signaling-dependent expression of this protein in multiple epithelial-derived RAS-driven malignancies as well as in vivo. Here, CDCP1 is linked to lung cancer.